ZEVTERA is the first and only U.S. Food and Drug Administration-approved cephalosporin indicated to treat Staphylococcus aureus bacteremia (SAB), including right-sided endocarditis, caused by the ...
(RTTNews) - The U.S. Food and Drug Administration has approved Basilea Pharmaceutica International Ltd.'s new Zevtera Antibiotic (ceftobiprole medocaril sodium for injection) for three different ...
Zevtera is supplied as a single-dose vial containing 667mg of ceftobiprole medocaril sodium as a lyophilized powder for reconstitution. Zevtera ® (ceftobiprole medocaril sodium for injection) is now ...
Basilea announces commercial availability of antibiotic Zevtera® (ceftobiprole) in the United States
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
Zevtera is a cephalosporin antibacterial with in vitro activity against gram-positive and gram-negative bacteria, including methicillin-resistant and susceptible Staphylococcus aureus. The Food and ...
The US Food and Drug Administration (FDA) has approved Basilea Pharmaceutica’s intravenous cephalosporin antibiotic for three indications, providing an additional treatment option for a number of ...
Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...
LONDON (MarketWatch) -- Shares of Basilea Pharmaceutica skidded Tuesday after the Swiss drugmaker saw approval for a skin-infection drug delayed, leading the company to file an arbitration claim ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results